Medical Journals

Proangiogenesis Action of the Thyroid Hormone Analog 3,5-diiodothyropropionic Acid (Ditpa) is Initiated at the Cell Surface and is Integrin Mediated.

Authors:
  • Mousa Shaker A
  • O’Connor Laura
  • Davis Faith B
  • Davis Paul J

From: The Pharmaceutical Research Institute and Albany College of Pharmacy, New York 12208, USA.

Endocrinology

  • Publish Date: Apr 2006
  • ISSN: 0013-7227
  • Volume: 147
  • Issue: 4
  • Pages: 1602-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mousa Shaker A, O'Connor Laura, Davis Faith B, et al. Proangiogenesis Action of the Thyroid Hormone Analog 3,5-diiodothyropropionic Acid (Ditpa) is Initiated at the Cell Surface and is Integrin Mediated.. Endocrinology Apr 2006;147:1602-7

Abstract

We have recently described the proangiogenesis effects of thyroid hormone in the chick chorioallantoic membrane (CAM) model. Generation of new blood vessels from existing vessels was promoted 2- to 3-fold by either T(4) or T(3) at 10(-8)-10(-7) M total hormone concentrations. In the present studies, nanomolar concentrations of 3,5-diiodothyropropionic acid (DITPA), a thyroid hormone analog with inotropic but not chronotropic properties, exhibited potent proangiogenic activity that was comparable to that obtained with T(3) and T(4) in both the CAM model and in an in vitro three-dimensional human microvascular endothelial sprouting assay. The proangiogenesis effect of DITPA was inhibited by tetraiodothyroacetic acid, a thyroid hormone analog that competes with T(4) and T(3) for a novel cell surface hormone receptor site on integrin alphavbeta3. The thyroid hormone analogs DITPA, T(4), and T(4)-agarose, as well as basic fibroblast growth factor (b-FGF) and vascular endothelial cell growth factor, demonstrated comparable proangiogenic effects in the CAM model and in the three-dimensional human microvascular endothelial sprouting model. The proangiogenesis effect of either DITPA or b-FGF was blocked by PD 98059, an inhibitor of the ERK1/2 signal transduction cascade. Additionally, a specific integrin alphavbeta3 small molecule antagonist, XT199, effectively inhibited the proangiogenesis effect of DITPA and b-FGF. Thus, the proangiogenesis actions of thyroid hormone and its analog DITPA are initiated at the plasma membrane, apparently at integrin alphavbeta3, and are MAPK dependent.

Mesh Headings (Keywords): Animals, Cell Membrane, Chick Embryo, Diiodothyronines, Fibroblast Growth Factor 2, Humans, Integrin alphaVbeta3, MAP Kinase Signaling System, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinase 3, Neovascularization, Physiologic, Propionic Acids, Thyroxine


Check for Full Text / PubMed Unique Identifier (PMID): 16384862


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.